Showing results (411-420 of 438) with videos related to

Sort By:
Pageof 44
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer riskMary E Platek, Peter G Shields, Catalin Marian, et al.
Respiratory Research|May 20, 2025
Lung lipids associated with smoking and ECIG use in a cross-sectional study and clinical trialJoseph P McElroy, Min-Ae Song, John R Barr, et al.
JAMA Oncology|March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal CancerHeather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 20, 2019
A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of ExposureEllen Meier, Bruce R Lindgren, Amanda Anderson, et al.
Communications Biology|July 26, 2019
Canine osteosarcoma genome sequencing identifies recurrent mutations in <i>DMD</i> and the histone methyltransferase gene <i>SETD2</i>Heather L Gardner, Karthigayini Sivaprakasam, Natalia Briones, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapyAdam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Cancer Investigation|October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint InhibitorsSandip H Patel, Songzhu Zhao, Mingjia Li, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung CancerAlexander Wong, Maria Riley, Songzhu Zhao, et al.
Pageof 44